Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS2W
Performance in the last:
Follow this Portfolio
1D -0.5 %
1W -0.9 %
2W -3.0 %
1M -8.5 %
3M -5.2 %
6M 4.2 %
9M -68.2 %
1Y -70.4 %
Alpha
-85.6%
Beta
0.44
sharpe-R
-0.87
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.97
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-10-18 07:52:19
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -75.48%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.92% 0.21%
BLUE bluebird bio, Inc. Sell -4.69% 0%
BLFS BioLife Solutions, Inc. Sell -5.95% 1.11%
SIGA SIGA Technologies, Inc. Sell -6.51% -8.1%
The percentage of cash held in the portfolio is: 104.22%
** The description of each asset is available Here

The latest 5 Compositions change

2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.92% 0.21%
BLUE bluebird bio, Inc. Sell -4.69% 0%
BLFS BioLife Solutions, Inc. Sell -5.95% 1.11%
SIGA SIGA Technologies, Inc. Sell -6.51% -8.1%
The percentage of cash held in the portfolio is: 104.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Buy All -3.17%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 13.21% 3.06%
THC Tenet Healthcare Corporation Sell -7.15% -4.65%
BLUE bluebird bio, Inc. Sell -4.58% 1.67%
BLFS BioLife Solutions, Inc. Sell -5.86% 1.92%
SIGA SIGA Technologies, Inc. Sell -6.22% -3.98%
The percentage of cash held in the portfolio is: 110.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
BHVN Sell All -2.43%
RGNX Buy All -14.97%
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 13.43% 0.04%
TDOC Teladoc Health, Inc. Buy 12.18% -5.16%
THC Tenet Healthcare Corporation Sell -6.78% 0.93%
RGNX REGENXBIO Inc. Sell -7.46% -9.09%
BLUE bluebird bio, Inc. Sell -4.76% -2.04%
BLFS BioLife Solutions, Inc. Sell -6% -0.17%
SIGA SIGA Technologies, Inc. Sell -6.18% -3.21%
The percentage of cash held in the portfolio is: 105.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Sell All -4.95%
PCRX Sell All 8.44%
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 12.27% -4.19%
PCRX Pacira BioSciences, Inc. Buy 13.81% 7.77%
BHVN Biohaven Ltd. Buy 13.57% 1.86%
TDOC Teladoc Health, Inc. Buy 12.36% -3.06%
THC Tenet Healthcare Corporation Sell -6.75% 0.59%
RGNX REGENXBIO Inc. Sell -7.18% -5.78%
BLUE bluebird bio, Inc. Sell -4.82% -4.08%
BLFS BioLife Solutions, Inc. Sell -5.74% 3.42%
SIGA SIGA Technologies, Inc. Sell -6.25% -5.05%
The percentage of cash held in the portfolio is: 78.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
WBA Sell All 1.66%
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.77% -0.33%
VREX Varex Imaging Corporation Buy 12.08% -5.79%
PCRX Pacira BioSciences, Inc. Buy 13.27% 3.52%
BHVN Biohaven Ltd. Buy 13% -2.46%
TDOC Teladoc Health, Inc. Buy 12.75% 0%
THC Tenet Healthcare Corporation Sell -6.62% 2.53%
RGNX REGENXBIO Inc. Sell -6.72% 1.18%
BLUE bluebird bio, Inc. Sell -4.64% 0%
BLFS BioLife Solutions, Inc. Sell -5.64% 5.13%
SIGA SIGA Technologies, Inc. Sell -6% -0.92%
The percentage of cash held in the portfolio is: 65.76%
New Assets Added
  • TDOC
Assets Removed
None
Assets Rebalanced
None
2024-10-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.63% -1.66%
VREX Varex Imaging Corporation Buy 12.39% -3.52%
PCRX Pacira BioSciences, Inc. Buy 13.3% 3.52%
BHVN Biohaven Ltd. Buy 12.98% -2.81%
THC Tenet Healthcare Corporation Sell -6.69% 1.7%
RGNX REGENXBIO Inc. Sell -6.73% 1.18%
BLUE bluebird bio, Inc. Sell -4.65% 0%
BLFS BioLife Solutions, Inc. Sell -5.96% 0%
SIGA SIGA Technologies, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 78.69%
New Assets Added
  • BLFS
  • SIGA
Assets Removed
Asset Action Perf %
ALDX Buy All 3.33%
Assets Rebalanced
None
2024-10-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.83% 0.22%
VREX Varex Imaging Corporation Buy 12.12% -5.37%
PCRX Pacira BioSciences, Inc. Buy 13.32% 4.05%
BHVN Biohaven Ltd. Buy 13.31% 0%
ALDX Aldeyra Therapeutics, Inc. Sell -7.3% 2.78%
THC Tenet Healthcare Corporation Sell -6.53% 3.82%
RGNX REGENXBIO Inc. Sell -6.91% -1.82%
BLUE bluebird bio, Inc. Sell -4.63% 0%
The percentage of cash held in the portfolio is: 73.79%
New Assets Added
  • BLUE
Assets Removed
Asset Action Perf %
BLUE Sell All NA
LXRX Buy All NA
KURA Buy All NA
Assets Rebalanced
None
2024-10-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.47% -2.1%
VREX Varex Imaging Corporation Buy 12% -5.79%
PCRX Pacira BioSciences, Inc. Buy 13.54% 6.25%
BLUE bluebird bio, Inc. Buy 10.48% 0%
BHVN Biohaven Ltd. Buy 13.25% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.25% -7.01%
KURA Kura Oncology, Inc. Sell -4.43% 9.74%
ALDX Aldeyra Therapeutics, Inc. Sell -7.31% 2.22%
THC Tenet Healthcare Corporation Sell -6.59% 2.47%
RGNX REGENXBIO Inc. Sell -6.88% -1.82%
The percentage of cash held in the portfolio is: 68.7%
New Assets Added
  • BHVN
Assets Removed
None
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
WBA Walgreens Boots Alliance, Inc. Buy 12.12% -3.75%
VREX Varex Imaging Corporation Buy 12.21% -3.1%
PCRX Pacira BioSciences, Inc. Buy 13.83% 9.77%
BLUE bluebird bio, Inc. Buy 11.36% 9.62%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.22% -7.64%
KURA Kura Oncology, Inc. Sell -4.41% 8.98%
ALDX Aldeyra Therapeutics, Inc. Sell -7.31% 1.11%
THC Tenet Healthcare Corporation Sell -6.67% 0.11%
RGNX REGENXBIO Inc. Sell -6.94% -3.96%
The percentage of cash held in the portfolio is: 81.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All 10.09%
Assets Rebalanced
None
2024-10-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 14.83% 17.51%
WBA Walgreens Boots Alliance, Inc. Buy 12.08% -4.3%
VREX Varex Imaging Corporation Buy 12.06% -4.45%
PCRX Pacira BioSciences, Inc. Buy 13.33% 5.58%
BLUE bluebird bio, Inc. Buy 10.38% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.98% -2.55%
KURA Kura Oncology, Inc. Sell -4.46% 8.27%
ALDX Aldeyra Therapeutics, Inc. Sell -7.17% 3.15%
THC Tenet Healthcare Corporation Sell -6.69% 0%
RGNX REGENXBIO Inc. Sell -6.69% 0%
The percentage of cash held in the portfolio is: 67.31%
New Assets Added
  • BLUE
  • THC
  • RGNX
Assets Removed
None
Assets Rebalanced
None
2024-10-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 13.86% 8.31%
WBA Walgreens Boots Alliance, Inc. Buy 12.29% -3.97%
VREX Varex Imaging Corporation Buy 12.74% -0.5%
PCRX Pacira BioSciences, Inc. Buy 13.01% 1.66%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.96% -0.64%
KURA Kura Oncology, Inc. Sell -4.77% 3.08%
ALDX Aldeyra Therapeutics, Inc. Sell -7.35% 2.04%
The percentage of cash held in the portfolio is: 65.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMI Sell All -10.07%
KIDS Buy All 16.7%
Assets Rebalanced
None
2024-10-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 12.25% -3.03%
PDSB PDS Biotechnology Corporation Buy 14.32% 13.35%
WBA Walgreens Boots Alliance, Inc. Buy 12.49% -1.1%
VREX Varex Imaging Corporation Buy 12.64% 0%
PCRX Pacira BioSciences, Inc. Buy 12.64% 0%
KIDS OrthoPediatrics Corp. Sell -6.28% 12.77%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.86% 0%
KURA Kura Oncology, Inc. Sell -4.79% 1.41%
ALDX Aldeyra Therapeutics, Inc. Sell -7.4% 0.19%
The percentage of cash held in the portfolio is: 59%
New Assets Added
  • VREX
  • PCRX
Assets Removed
Asset Action Perf %
CHRS Buy All 0.95%
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 12.8% 0%
PDSB PDS Biotechnology Corporation Buy 12.8% 0%
WBA Walgreens Boots Alliance, Inc. Buy 12.8% 0%
CHRS Coherus BioSciences, Inc. Sell -6.32% 0%
KIDS OrthoPediatrics Corp. Sell -6.21% 14.86%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.02% -1.91%
KURA Kura Oncology, Inc. Sell -4.85% 1.51%
ALDX Aldeyra Therapeutics, Inc. Sell -7.65% -1.85%
The percentage of cash held in the portfolio is: 91.66%
New Assets Added
  • OMI
  • PDSB
  • WBA
Assets Removed
Asset Action Perf %
TDOC Sell All 4.57%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.59% 3.96%
CHRS Coherus BioSciences, Inc. Sell -6.36% -0.95%
KIDS OrthoPediatrics Corp. Sell -6.12% 15.83%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.82% 1.91%
KURA Kura Oncology, Inc. Sell -4.82% 1.82%
ALDX Aldeyra Therapeutics, Inc. Sell -7.44% 0.56%
The percentage of cash held in the portfolio is: 116.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
VNDA Sell All -4.44%
SRNE Sell All -16.67%
LLY Sell All -2.75%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SRNE Sorrento Therapeutics, Inc. Buy 10.15% -40%
LLY Eli Lilly and Company Buy 12.7% -1.12%
TDOC Teladoc Health, Inc. Buy 13.05% 4.7%
VNDA Vanda Pharmaceuticals Inc. Buy 12.92% -2.22%
CHRS Coherus BioSciences, Inc. Sell -6.12% 5.62%
KIDS OrthoPediatrics Corp. Sell -6.32% 15.6%
LXRX Lexicon Pharmaceuticals, Inc. Sell -4.86% 3.82%
KURA Kura Oncology, Inc. Sell -4.99% 1.26%
ALDX Aldeyra Therapeutics, Inc. Sell -7.7% 0%
The percentage of cash held in the portfolio is: 81.18%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
ESPR Sell All -7.47%
AGEN Sell All -15.18%
MRSN Sell All -14.69%
SIGA Buy All 10.12%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 13.99% -5.17%
SRNE Sorrento Therapeutics, Inc. Buy 9.6% -43.33%
AGEN Agenus Inc. Buy 13.05% -12.82%
LLY Eli Lilly and Company Buy 12.72% -1.13%
MRSN Mersana Therapeutics, Inc. Buy 12.09% -10.66%
TDOC Teladoc Health, Inc. Buy 13.61% 9.02%
VNDA Vanda Pharmaceuticals Inc. Buy 13.23% 0%
SIGA SIGA Technologies, Inc. Sell -7.12% -6.66%
CHRS Coherus BioSciences, Inc. Sell -6.19% 4.76%
KIDS OrthoPediatrics Corp. Sell -6.56% 12.52%
LXRX Lexicon Pharmaceuticals, Inc. Sell -5.06% 0%
KURA Kura Oncology, Inc. Sell -5.06% 0%
The percentage of cash held in the portfolio is: 41.7%
New Assets Added
  • VNDA
  • LXRX
  • KURA
Assets Removed
Asset Action Perf %
PDSB Sell All 3.99%
NVAX Sell All 4.65%
RGNX Sell All -11.8%
VKTX Sell All -12.12%
CARA Buy All 0.36%
BGNE Buy All -6.64%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 13.52% 4.32%
NVAX Novavax, Inc. Buy 12.8% 0.79%
ESPR Esperion Therapeutics, Inc. Buy 13.22% -6.32%
RGNX REGENXBIO Inc. Buy 13.25% -8.18%
SRNE Sorrento Therapeutics, Inc. Buy 13.51% -16.67%
AGEN Agenus Inc. Buy 12.8% -10.62%
LLY Eli Lilly and Company Buy 12.08% -1.76%
MRSN Mersana Therapeutics, Inc. Buy 11.94% -7.82%
TDOC Teladoc Health, Inc. Buy 12.8% 7.17%
VKTX Viking Therapeutics, Inc. Buy 12.09% -7.75%
CARA Cara Therapeutics, Inc. Sell -6.95% -7.12%
SIGA SIGA Technologies, Inc. Sell -7.17% -12.25%
BGNE BeiGene, Ltd. Sell -6.57% -2.57%
CHRS Coherus BioSciences, Inc. Sell -6.15% 0.95%
KIDS OrthoPediatrics Corp. Sell -6.3% 12.23%
The percentage of cash held in the portfolio is: 5.14%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
MRSN Sell -1.53%
LLY Sell -3.18%
TDOC Sell -2.86%
SRNE Buy 0.79%
AGEN Buy 1.65%
NVAX Buy 2.12%
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 12.62% 6.31%
NVAX Novavax, Inc. Buy 9.87% 1.65%
ESPR Esperion Therapeutics, Inc. Buy 12.48% -3.45%
RGNX REGENXBIO Inc. Buy 12.16% -8.03%
SRNE Sorrento Therapeutics, Inc. Buy 15.4% 16.67%
AGEN Agenus Inc. Buy 11.26% -1.52%
LLY Eli Lilly and Company Buy 14.03% -1.45%
TDOC Teladoc Health, Inc. Buy 14.48% 8.16%
MRSN Mersana Therapeutics, Inc. Buy 13.7% 2.37%
VKTX Viking Therapeutics, Inc. Buy 12.01% 0%
CARA Cara Therapeutics, Inc. Sell -6.39% -7.47%
SIGA SIGA Technologies, Inc. Sell -6.57% -12.25%
BGNE BeiGene, Ltd. Sell -6.04% -2.91%
CHRS Coherus BioSciences, Inc. Sell -5.53% 2.86%
KIDS OrthoPediatrics Corp. Sell -6.08% 7.53%
The percentage of cash held in the portfolio is: 2.61%
New Assets Added
  • VKTX
Assets Removed
Asset Action Perf %
IRTC Sell All -8.63%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 12.18% 1.99%
NVAX Novavax, Inc. Buy 9.66% -1.1%
ESPR Esperion Therapeutics, Inc. Buy 13.01% 0%
RGNX REGENXBIO Inc. Buy 13.11% -1.42%
SRNE Sorrento Therapeutics, Inc. Buy 13.29% 0%
AGEN Agenus Inc. Buy 11.73% 2.02%
LLY Eli Lilly and Company Buy 13.87% -3.21%
TDOC Teladoc Health, Inc. Buy 15.13% 12.36%
MRSN Mersana Therapeutics, Inc. Buy 13.53% 0.47%
IRTC iRhythm Technologies, Inc. Buy 12.49% -7.28%
CARA Cara Therapeutics, Inc. Sell -6.09% -1.78%
SIGA SIGA Technologies, Inc. Sell -6.25% -6.13%
BGNE BeiGene, Ltd. Sell -5.94% -0.51%
CHRS Coherus BioSciences, Inc. Sell -5.73% 0%
KIDS OrthoPediatrics Corp. Sell -6.4% 3.28%
The percentage of cash held in the portfolio is: 2.4%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
RGNX Buy 1.02%
LLY Buy 1.67%
PDSB Buy 2.22%
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.1% 3.65%
NVAX Novavax, Inc. Buy 9.92% 1.81%
ESPR Esperion Therapeutics, Inc. Buy 13.26% 2.3%
RGNX REGENXBIO Inc. Buy 12.14% 1.89%
AGEN Agenus Inc. Buy 12.05% 5.06%
LLY Eli Lilly and Company Buy 11.11% -3.08%
SRNE Sorrento Therapeutics, Inc. Buy 12.14% -8.33%
IRTC iRhythm Technologies, Inc. Buy 12.53% -6.66%
TDOC Teladoc Health, Inc. Buy 15.12% 12.61%
MRSN Mersana Therapeutics, Inc. Buy 12.98% -3.32%
CARA Cara Therapeutics, Inc. Sell -5.67% 4.98%
SIGA SIGA Technologies, Inc. Sell -6.16% -4.93%
BGNE BeiGene, Ltd. Sell -5.93% -0.63%
CHRS Coherus BioSciences, Inc. Sell -5.66% 0.95%
KIDS OrthoPediatrics Corp. Sell -6.59% 0%
The percentage of cash held in the portfolio is: 8.65%
New Assets Added
  • KIDS
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ESPR Buy 1.41%
RGNX Buy 1.46%
SRNE Buy 1.63%
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.16% 1.66%
NVAX Novavax, Inc. Buy 10.38% 3.94%
RGNX REGENXBIO Inc. Buy 10.78% 0.24%
ESPR Esperion Therapeutics, Inc. Buy 10.88% 1.15%
SRNE Sorrento Therapeutics, Inc. Buy 10.39% -11.67%
AGEN Agenus Inc. Buy 12.06% 2.53%
LLY Eli Lilly and Company Buy 11.62% -1.23%
IRTC iRhythm Technologies, Inc. Buy 13.25% -3.8%
TDOC Teladoc Health, Inc. Buy 13.89% 0.87%
MRSN Mersana Therapeutics, Inc. Buy 12.86% -6.64%
CARA Cara Therapeutics, Inc. Sell -5.83% 4.63%
SIGA SIGA Technologies, Inc. Sell -6.41% -6.39%
BGNE BeiGene, Ltd. Sell -6.04% -0.09%
CHRS Coherus BioSciences, Inc. Sell -5.86% 0%
The percentage of cash held in the portfolio is: 7.88%
New Assets Added
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.82% -0.33%
NVAX Novavax, Inc. Buy 10.56% 7.17%
RGNX REGENXBIO Inc. Buy 10.72% 1.02%
ESPR Esperion Therapeutics, Inc. Buy 11.65% 9.77%
SRNE Sorrento Therapeutics, Inc. Buy 8.7% -25%
AGEN Agenus Inc. Buy 12.25% 5.56%
LLY Eli Lilly and Company Buy 11.46% -1.21%
IRTC iRhythm Technologies, Inc. Buy 13.59% 0%
TDOC Teladoc Health, Inc. Buy 13.59% 0%
MRSN Mersana Therapeutics, Inc. Buy 13.59% 0%
CARA Cara Therapeutics, Inc. Sell -5.65% 6.41%
SIGA SIGA Technologies, Inc. Sell -6.25% -5.19%
BGNE BeiGene, Ltd. Sell -6.03% -1.13%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • TDOC
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.02% 1.33%
NVAX Novavax, Inc. Buy 9.28% -6.14%
RGNX REGENXBIO Inc. Buy 10.2% -4.17%
ESPR Esperion Therapeutics, Inc. Buy 10.71% 0.57%
SRNE Sorrento Therapeutics, Inc. Buy 11.64% 0%
AGEN Agenus Inc. Buy 11.64% 0%
LLY Eli Lilly and Company Buy 11.64% 0%
CARA Cara Therapeutics, Inc. Sell -5.82% 3.91%
SIGA SIGA Technologies, Inc. Sell -6.25% -4.79%
BGNE BeiGene, Ltd. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 42.9%
New Assets Added
  • SRNE
  • AGEN
  • LLY
  • BGNE
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.12% 2.99%
NVAX Novavax, Inc. Buy 9.51% -3.23%
RGNX REGENXBIO Inc. Buy 10.58% 0%
ESPR Esperion Therapeutics, Inc. Buy 10.58% 0%
CARA Cara Therapeutics, Inc. Sell -6.3% -4.63%
SIGA SIGA Technologies, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 71.42%
New Assets Added
  • RGNX
  • ESPR
  • SIGA
Assets Removed
None
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.8% 0%
NVAX Novavax, Inc. Buy 9.8% 0%
CARA Cara Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 86.4%
New Assets Added
  • PDSB
  • NVAX
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
KIDS Sell All 12.95%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 12.4% 15.23%
The percentage of cash held in the portfolio is: 87.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
OFIX Buy All -7.98%
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 11.76% 8.86%
OFIX Orthofix Medical Inc. Sell -6.14% -3.87%
The percentage of cash held in the portfolio is: 94.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Sell All 4.94%
VCYT Sell All 3.64%
INGN Sell All 4.71%
CPRX Sell All 13.33%
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ICUI ICU Medical, Inc. Buy 11.08% 3.93%
VCYT Veracyte, Inc. Buy 10.49% 5.54%
INGN Inogen, Inc. Buy 10.21% 6.86%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.37% 11.86%
KIDS OrthoPediatrics Corp. Buy 12.21% 13.75%
OFIX Orthofix Medical Inc. Sell -6.08% -3.62%
The percentage of cash held in the portfolio is: 50.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All 12.88%
EXEL Sell All -0.72%
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 11.9% 11.63%
EXEL Exelixis, Inc. Buy 11.17% -0.15%
ICUI ICU Medical, Inc. Buy 11.05% 2.58%
VCYT Veracyte, Inc. Buy 10.62% 5.74%
INGN Inogen, Inc. Buy 10.39% 7.54%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.61% 13.06%
KIDS OrthoPediatrics Corp. Buy 11.18% 3.08%
OFIX Orthofix Medical Inc. Sell -6.05% -2%
The percentage of cash held in the portfolio is: 28.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 6.2%
GKOS Sell All 6.82%
AXSM Sell All 3.09%
Assets Rebalanced
None
2024-08-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 11.16% 6.86%
GKOS Glaukos Corporation Buy 11.16% 8.37%
AXSM Axsome Therapeutics, Inc. Buy 11.16% 5.57%
MD Pediatrix Medical Group, Inc. Buy 11.86% 11.94%
EXEL Exelixis, Inc. Buy 11.16% 0.26%
ICUI ICU Medical, Inc. Buy 11.03% 2.98%
VCYT Veracyte, Inc. Buy 10.78% 7.91%
INGN Inogen, Inc. Buy 10.45% 8.83%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.16% 9.23%
KIDS OrthoPediatrics Corp. Buy 11.16% 3.44%
OFIX Orthofix Medical Inc. Sell -6.04% -2.43%
The percentage of cash held in the portfolio is: -5.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
CVS Buy All -1.71%
Assets Rebalanced
Asset Action Weight
INGN Sell -1.54%
EXEL Sell -1.16%
THC Sell -1.29%
KIDS Sell -1.32%
GKOS Sell -1.41%
CPRX Sell -2.25%
AXSM Sell -2.49%
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.6% 7.18%
GKOS Glaukos Corporation Buy 12.78% 9.17%
AXSM Axsome Therapeutics, Inc. Buy 13.15% 0.76%
EXEL Exelixis, Inc. Buy 12.32% -0.64%
MD Pediatrix Medical Group, Inc. Buy 11.57% 8.1%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.46% 8.58%
INGN Inogen, Inc. Buy 12.26% 10.11%
ICUI ICU Medical, Inc. Buy 11.32% 4.68%
VCYT Veracyte, Inc. Buy 11.05% 9.61%
KIDS OrthoPediatrics Corp. Buy 12.05% -1.01%
CVS CVS Health Corporation Sell -7.53% -0.93%
OFIX Orthofix Medical Inc. Sell -6% -0.62%
The percentage of cash held in the portfolio is: -9.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.93%
CDXS Buy All 11.82%
Assets Rebalanced
Asset Action Weight
ICUI Sell -1.65%
VCYT Sell -2.53%
INGN Sell -1.39%
AXSM Buy 1.69%
2024-08-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.55% 6.15%
GKOS Glaukos Corporation Buy 12.62% 7.22%
AXSM Axsome Therapeutics, Inc. Buy 11.45% 0.11%
EXEL Exelixis, Inc. Buy 12.37% -0.79%
MD Pediatrix Medical Group, Inc. Buy 11.51% 6.96%
VCYT Veracyte, Inc. Buy 13.58% 8.98%
INGN Inogen, Inc. Buy 13.47% 8.05%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.56% 8.8%
ICUI ICU Medical, Inc. Buy 13.02% 4.47%
KIDS OrthoPediatrics Corp. Buy 12.24% 0%
VREX Varex Imaging Corporation Sell -5.81% 3.08%
CDXS Codexis, Inc. Sell -5.1% 14.85%
CVS CVS Health Corporation Sell -7.47% 0.43%
OFIX Orthofix Medical Inc. Sell -6.1% -1.75%
The percentage of cash held in the portfolio is: -1.9%
New Assets Added
  • KIDS
Assets Removed
Asset Action Perf %
RCM Sell All -1.13%
BLUE Buy All 34.26%
Assets Rebalanced
None
2024-08-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 12.86% -1.27%
THC Tenet Healthcare Corporation Buy 12.8% 3.64%
GKOS Glaukos Corporation Buy 12.8% 4.07%
AXSM Axsome Therapeutics, Inc. Buy 11.87% -0.7%
EXEL Exelixis, Inc. Buy 13.23% 1.55%
MD Pediatrix Medical Group, Inc. Buy 11.82% 5.19%
VCYT Veracyte, Inc. Buy 13% -0.17%
INGN Inogen, Inc. Buy 13.15% 1.03%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.73% 5.46%
ICUI ICU Medical, Inc. Buy 12.74% -2.17%
BLUE bluebird bio, Inc. Sell -5.63% 9.26%
VREX Varex Imaging Corporation Sell -5.2% 16.95%
CDXS Codexis, Inc. Sell -5.35% 14.55%
CVS CVS Health Corporation Sell -7.57% 3.46%
OFIX Orthofix Medical Inc. Sell -6.26% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OFIX
Assets Removed
Asset Action Perf %
RVNC Buy All -95.85%
Assets Rebalanced
Asset Action Weight
MD Sell -1.88%
AXSM Sell -2.45%
THC Sell -2.14%
GKOS Sell -2.2%
RCM Buy 2.86%
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.6% -1.13%
GKOS Glaukos Corporation Buy 14.26% 3.2%
THC Tenet Healthcare Corporation Buy 14.19% 2.7%
AXSM Axsome Therapeutics, Inc. Buy 13.74% -0.61%
MD Pediatrix Medical Group, Inc. Buy 12.75% 2.08%
EXEL Exelixis, Inc. Buy 12.79% 2.45%
ICUI ICU Medical, Inc. Buy 12.49% 0%
INGN Inogen, Inc. Buy 12.49% 0%
VCYT Veracyte, Inc. Buy 12.49% 0%
CPRX Catalyst Pharmaceuticals, Inc. Buy 12.49% 0%
RVNC Revance Therapeutics, Inc. Sell -5.21% 12.46%
BLUE bluebird bio, Inc. Sell -5.56% 6.48%
VREX Varex Imaging Corporation Sell -5.27% 12.25%
CDXS Codexis, Inc. Sell -5.73% 4.55%
CVS CVS Health Corporation Sell -7.52% -0.07%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ICUI
  • INGN
  • VCYT
  • CPRX
Assets Removed
None
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.67% -1.2%
GKOS Glaukos Corporation Buy 13.83% -0.69%
THC Tenet Healthcare Corporation Buy 13.86% -0.46%
AXSM Axsome Therapeutics, Inc. Buy 13.65% -1.95%
MD Pediatrix Medical Group, Inc. Buy 12.58% 0%
EXEL Exelixis, Inc. Buy 12.58% 0%
RVNC Revance Therapeutics, Inc. Sell -5.01% 16.32%
BLUE bluebird bio, Inc. Sell -5.21% 12.96%
VREX Varex Imaging Corporation Sell -5.33% 11.79%
CDXS Codexis, Inc. Sell -5.53% 8.48%
CVS CVS Health Corporation Sell -7.4% 2.32%
The percentage of cash held in the portfolio is: 52.32%
New Assets Added
  • MD
  • EXEL
Assets Removed
Asset Action Perf %
TNDM Sell All -11.11%
CERS Sell All -11.06%
Assets Rebalanced
None
2024-08-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.57% -1.27%
TNDM Tandem Diabetes Care, Inc. Buy 11.46% 4.13%
CERS Cerus Corporation Buy 10.26% -6.81%
GKOS Glaukos Corporation Buy 13.79% 0%
THC Tenet Healthcare Corporation Buy 13.79% 0%
AXSM Axsome Therapeutics, Inc. Buy 13.79% 0%
RVNC Revance Therapeutics, Inc. Sell -5.42% 8.61%
BLUE bluebird bio, Inc. Sell -5.6% 5.56%
VREX Varex Imaging Corporation Sell -5.37% 10.25%
CDXS Codexis, Inc. Sell -5.84% 2.42%
CVS CVS Health Corporation Sell -7.57% -0.92%
The percentage of cash held in the portfolio is: 57.15%
New Assets Added
  • GKOS
  • THC
  • AXSM
Assets Removed
None
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.62% -1.27%
TNDM Tandem Diabetes Care, Inc. Buy 10.84% -2.11%
CERS Cerus Corporation Buy 10.46% -5.53%
RVNC Revance Therapeutics, Inc. Sell -5.42% 9.2%
BLUE bluebird bio, Inc. Sell -5.47% 8.33%
VREX Varex Imaging Corporation Sell -5.71% 5.08%
CDXS Codexis, Inc. Sell -5.86% 2.73%
CVS CVS Health Corporation Sell -7.54% 0%
The percentage of cash held in the portfolio is: 99.08%
New Assets Added
  • CVS
Assets Removed
None
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.74% -0.57%
TNDM Tandem Diabetes Care, Inc. Buy 11.12% 0%
CERS Cerus Corporation Buy 11.12% 0%
RVNC Revance Therapeutics, Inc. Sell -5.69% 5.04%
BLUE bluebird bio, Inc. Sell -6.16% -2.78%
VREX Varex Imaging Corporation Sell -6.05% 0%
CDXS Codexis, Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 91.97%
New Assets Added
  • TNDM
  • CERS
  • VREX
  • CDXS
Assets Removed
None
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.8% 0%
RVNC Revance Therapeutics, Inc. Sell -6% 0%
BLUE bluebird bio, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 102.2%
New Assets Added
  • RCM
  • RVNC
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SNDX Sell All 3.15%
SAGE Sell All 14.04%
ATXS Sell All 14.43%
TVTX Sell All 3.06%
BLUE Sell All 24%
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 10.84% 3.63%
SAGE Sage Therapeutics, Inc. Buy 11.67% 11.6%
ATXS Astria Therapeutics, Inc. Buy 10.96% 15.51%
TVTX Travere Therapeutics, Inc. Buy 9% 1.69%
BLUE bluebird bio, Inc. Buy 9.86% 14%
The percentage of cash held in the portfolio is: 47.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Sell All 18.37%
AVXL Sell All 31.04%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 10.15% 12.24%
AVXL Anavex Life Sciences Corp. Buy 10.08% 21.51%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.03% 2.26%
SAGE Sage Therapeutics, Inc. Buy 11.56% 7.15%
ATXS Astria Therapeutics, Inc. Buy 10.76% 9.91%
TVTX Travere Therapeutics, Inc. Buy 9.43% 3.27%
BLUE bluebird bio, Inc. Buy 9.37% 5%
The percentage of cash held in the portfolio is: 27.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
MCRB Sell All 25.9%
MODV Buy All 7.31%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 10.05% 12.76%
AVXL Anavex Life Sciences Corp. Buy 10.35% 26.61%
MCRB Seres Therapeutics, Inc. Buy 9.14% 29.5%
SNDX Syndax Pharmaceuticals, Inc. Buy 10.95% 2.88%
SAGE Sage Therapeutics, Inc. Buy 11.29% 6.1%
ATXS Astria Therapeutics, Inc. Buy 10.47% 8.44%
TVTX Travere Therapeutics, Inc. Buy 9.31% 3.37%
BLUE bluebird bio, Inc. Buy 10.12% 15%
MODV ModivCare Inc. Sell -4.5% 6.4%
The percentage of cash held in the portfolio is: 22.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
NKTR Sell All 4.65%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 10.26% 12.4%
CERS Cerus Corporation Buy 10.26% 20.41%
AVXL Anavex Life Sciences Corp. Buy 10.26% 31.26%
MCRB Seres Therapeutics, Inc. Buy 10.26% 52.11%
SNDX Syndax Pharmaceuticals, Inc. Buy 10.67% 4.96%
SAGE Sage Therapeutics, Inc. Buy 10.77% 5.93%
ATXS Astria Therapeutics, Inc. Buy 10.26% 11.19%
TVTX Travere Therapeutics, Inc. Buy 9.34% 8.43%
BLUE bluebird bio, Inc. Buy 10.26% 22%
MODV ModivCare Inc. Sell -4.6% -0.04%
The percentage of cash held in the portfolio is: 12.26%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
TVTX Sell -1.69%
ATXS Sell -1.05%
NKTR Sell -1.7%
BLUE Sell -2.15%
CERS Sell -3.11%
AVXL Sell -4.31%
MCRB Sell -6.62%
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.14% 13.95%
AVXL Anavex Life Sciences Corp. Buy 14.37% 29.27%
CERS Cerus Corporation Buy 13.55% 21.94%
MCRB Seres Therapeutics, Inc. Buy 14.51% 30.52%
TVTX Travere Therapeutics, Inc. Buy 10.96% 7.69%
ATXS Astria Therapeutics, Inc. Buy 11.83% 16.19%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.19% 9.92%
SAGE Sage Therapeutics, Inc. Buy 10.79% 6.02%
BLUE bluebird bio, Inc. Buy 13.74% 35%
MODV ModivCare Inc. Sell -4.7% -2.16%
The percentage of cash held in the portfolio is: -8.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
DNLI Buy All -10.12%
AGEN Buy All -21.82%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.85% 8.53%
AVXL Anavex Life Sciences Corp. Buy 14.73% 29.27%
CERS Cerus Corporation Buy 13.08% 14.8%
MCRB Seres Therapeutics, Inc. Buy 13.93% 22.3%
TVTX Travere Therapeutics, Inc. Buy 10.79% 3.37%
ATXS Astria Therapeutics, Inc. Buy 12.12% 16.09%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.27% 8.02%
SAGE Sage Therapeutics, Inc. Buy 10.74% 2.88%
BLUE bluebird bio, Inc. Buy 13.78% 32%
DNLI Denali Therapeutics Inc. Sell -5.77% -7.31%
AGEN Agenus Inc. Sell -5.52% -7.36%
MODV ModivCare Inc. Sell -4.58% 2.87%
The percentage of cash held in the portfolio is: 3.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -37.1%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.4% 5.43%
AVXL Anavex Life Sciences Corp. Buy 13.45% 9.53%
CERS Cerus Corporation Buy 13.22% 7.65%
MCRB Seres Therapeutics, Inc. Buy 12.34% 0.51%
TVTX Travere Therapeutics, Inc. Buy 11.6% 3.16%
ATXS Astria Therapeutics, Inc. Buy 12.41% 10.4%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.71% 4.12%
SAGE Sage Therapeutics, Inc. Buy 11.51% 2.31%
BLUE bluebird bio, Inc. Buy 12.71% 13%
DNLI Denali Therapeutics Inc. Sell -6.15% -6.21%
AGEN Agenus Inc. Sell -5.87% -5.92%
MODV ModivCare Inc. Sell -5.07% 0.28%
NUTX Nutex Health Inc. Sell -7.57% -9.91%
The percentage of cash held in the portfolio is: 13.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All -16.25%
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.65% -4.65%
AVXL Anavex Life Sciences Corp. Buy 12.84% 0.67%
CERS Cerus Corporation Buy 12.88% 1.02%
MCRB Seres Therapeutics, Inc. Buy 13.37% 4.83%
TVTX Travere Therapeutics, Inc. Buy 11.68% 0%
ATXS Astria Therapeutics, Inc. Buy 11.68% 0%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.68% 0%
SAGE Sage Therapeutics, Inc. Buy 11.68% 0%
BLUE bluebird bio, Inc. Buy 11.68% 0%
DNLI Denali Therapeutics Inc. Sell -5.8% 3.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.02% 0%
AGEN Agenus Inc. Sell -6.17% -7.23%
MODV ModivCare Inc. Sell -4.85% 8.17%
NUTX Nutex Health Inc. Sell -7.15% 0%
The percentage of cash held in the portfolio is: 20.84%
New Assets Added
  • TVTX
  • ATXS
  • SNDX
  • SAGE
  • BLUE
  • NUTX
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.89% -3.88%
AVXL Anavex Life Sciences Corp. Buy 12.9% 0%
CERS Cerus Corporation Buy 12.9% 0%
MCRB Seres Therapeutics, Inc. Buy 12.9% 0%
DNLI Denali Therapeutics Inc. Sell -5.93% 2.53%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.09% 0%
AGEN Agenus Inc. Sell -6.24% -7.09%
MODV ModivCare Inc. Sell -5.27% 1.49%
The percentage of cash held in the portfolio is: 72.93%
New Assets Added
  • AVXL
  • CERS
  • MCRB
Assets Removed
Asset Action Perf %
INGN Buy All -14.99%
Assets Rebalanced
None
2024-07-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.27% 0%
INGN Inogen, Inc. Sell -6.5% -7.56%
DNLI Denali Therapeutics Inc. Sell -5.87% 2.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.3% -4.37%
AGEN Agenus Inc. Sell -6.02% -4.13%
MODV ModivCare Inc. Sell -5.3% 0%
The percentage of cash held in the portfolio is: 117.73%
New Assets Added
  • NKTR
  • MODV
Assets Removed
None
Assets Rebalanced
None
2024-07-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Sell -6.34% -5.35%
DNLI Denali Therapeutics Inc. Sell -5.9% 2.02%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.24% -3.75%
AGEN Agenus Inc. Sell -5.76% 0%
The percentage of cash held in the portfolio is: 124.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
SUPN Sell All NA
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
SUPN Supernus Pharmaceuticals, Inc. Buy 12.44% -2.95%
INGN Inogen, Inc. Sell -6.34% -5.35%
DNLI Denali Therapeutics Inc. Sell -5.9% 2.02%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.24% -3.75%
AGEN Agenus Inc. Sell -5.76% 0%
The percentage of cash held in the portfolio is: 111.8%
New Assets Added
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
SUPN Supernus Pharmaceuticals, Inc. Buy 12.29% -3.84%
INGN Inogen, Inc. Sell -6% 0%
DNLI Denali Therapeutics Inc. Sell -6% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 105.71%
New Assets Added
  • INGN
  • DNLI
  • LXRX
Assets Removed
Asset Action Perf %
IBRX Sell All -0.8%
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 13.31% 4.98%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.65% 0.26%
The percentage of cash held in the portfolio is: 74.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
MASI Sell All -1.76%
TDOC Buy All -1.91%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 14.73% -1.06%
IBRX ImmunityBio, Inc. Buy 14.56% 16.69%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.28% -1.08%
TDOC Teladoc Health, Inc. Sell -6.03% 2.01%
The percentage of cash held in the portfolio is: 64.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All 15.18%
ATRC Sell All -10.48%
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 16.99% 15.18%
MASI Masimo Corporation Buy 14.33% -3.83%
IBRX ImmunityBio, Inc. Buy 14.71% 17.82%
ATRC AtriCure, Inc. Buy 11.51% -7.32%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.47% 0.41%
TDOC Teladoc Health, Inc. Sell -6.41% -4.12%
The percentage of cash held in the portfolio is: 36.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDGL Sell All 11.42%
ALT Buy All -14.06%
PEN Buy All 7.26%
Assets Rebalanced
None
2024-06-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.29% 9.24%
ACRS Aclaris Therapeutics, Inc. Buy 15.53% 2.68%
MASI Masimo Corporation Buy 14.97% -2%
IBRX ImmunityBio, Inc. Buy 14.91% 16.53%
ATRC AtriCure, Inc. Buy 12.29% -3.49%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.85% 0.9%
ALT Altimmune, Inc. Sell 12.54% -2.4%
PEN Penumbra, Inc. Sell -5.56% 5.05%
TDOC Teladoc Health, Inc. Sell -6.16% 2.41%
The percentage of cash held in the portfolio is: 21.34%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
MCRB Buy All -26.38%
ABUS Buy All 4.69%
Assets Rebalanced
None
2024-06-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.07% 5.07%
ACRS Aclaris Therapeutics, Inc. Buy 15.39% 0.89%
MASI Masimo Corporation Buy 15.01% -2.58%
IBRX ImmunityBio, Inc. Buy 13.46% 4.33%
ATRC AtriCure, Inc. Buy 12.84% 0%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.84% 0%
MCRB Seres Therapeutics, Inc. Sell -7.94% -22.48%
ABUS Arbutus Biopharma Corporation Sell -5.98% 7.81%
PEN Penumbra, Inc. Sell -5.51% 6.71%
ALT Altimmune, Inc. Sell -5.61% 5.11%
TDOC Teladoc Health, Inc. Sell -6.18% 3.02%
The percentage of cash held in the portfolio is: 54.59%
New Assets Added
  • ATRC
  • SUPN
Assets Removed
Asset Action Perf %
SGRY Sell All -11.04%
PDSB Sell All -15%
Assets Rebalanced
None
2024-06-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.14% 8.29%
ACRS Aclaris Therapeutics, Inc. Buy 15.08% 0.89%
SGRY Surgery Partners, Inc. Buy 13.44% -5.93%
MASI Masimo Corporation Buy 15.32% 1.46%
PDSB PDS Biotechnology Corporation Buy 13.79% -8.67%
IBRX ImmunityBio, Inc. Buy 12.65% 0%
MCRB Seres Therapeutics, Inc. Sell -7.34% -15.64%
ABUS Arbutus Biopharma Corporation Sell -5.97% 5.94%
PEN Penumbra, Inc. Sell -5.42% 6.4%
ALT Altimmune, Inc. Sell -5.47% 5.59%
TDOC Teladoc Health, Inc. Sell -6.33% -1.41%
The percentage of cash held in the portfolio is: 53.12%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
ARWR Sell All -8.52%
Assets Rebalanced
None
2024-06-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.13% 8.57%
ACRS Aclaris Therapeutics, Inc. Buy 15.01% 0.89%
SGRY Surgery Partners, Inc. Buy 13.43% -5.63%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.86% -2.6%
MASI Masimo Corporation Buy 15.2% 1.11%
PDSB PDS Biotechnology Corporation Buy 13.38% -11%
MCRB Seres Therapeutics, Inc. Sell -6.91% -9.28%
ABUS Arbutus Biopharma Corporation Sell -6.05% 4.38%
PEN Penumbra, Inc. Sell -5.74% 0.39%
ALT Altimmune, Inc. Sell -5.45% 5.43%
TDOC Teladoc Health, Inc. Sell -6.31% -1.61%
The percentage of cash held in the portfolio is: 52.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGIO Sell All -10.05%
Assets Rebalanced
None
2024-06-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGIO Agios Pharmaceuticals, Inc. Buy 10.6% -6.84%
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.06% 8.91%
ACRS Aclaris Therapeutics, Inc. Buy 15.47% 5.36%
SGRY Surgery Partners, Inc. Buy 13.18% -6.12%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 14.08% 0.27%
MASI Masimo Corporation Buy 15.03% 1.37%
PDSB PDS Biotechnology Corporation Buy 13.77% -7.17%
MCRB Seres Therapeutics, Inc. Sell -7.19% -15.31%
ABUS Arbutus Biopharma Corporation Sell -6.12% 1.87%
PEN Penumbra, Inc. Sell -5.68% 0.15%
ALT Altimmune, Inc. Sell -5.55% 2.4%
TDOC Teladoc Health, Inc. Sell -6.16% -0.5%
The percentage of cash held in the portfolio is: 41.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
EDIT Sell All -16.23%
RARE Sell All -2.72%
Assets Rebalanced
None
2024-06-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 13.64% 7.42%
AGIO Agios Pharmaceuticals, Inc. Buy 10.81% -1.22%
MDGL Madrigal Pharmaceuticals, Inc. Buy 6.77% 8.69%
ACRS Aclaris Therapeutics, Inc. Buy 15% 6.25%
SGRY Surgery Partners, Inc. Buy 12.84% -4.92%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.88% 2.83%
EDIT Editas Medicine, Inc. Buy 12.27% -9.11%
MASI Masimo Corporation Buy 14.26% 0%
PDSB PDS Biotechnology Corporation Buy 14.26% 0%
MCRB Seres Therapeutics, Inc. Sell -6.94% -15.64%
ABUS Arbutus Biopharma Corporation Sell -5.92% 1.25%
PEN Penumbra, Inc. Sell -5.47% 0.03%
ALT Altimmune, Inc. Sell -5.78% -5.59%
TDOC Teladoc Health, Inc. Sell -5.89% 0%
The percentage of cash held in the portfolio is: 16.26%
New Assets Added
  • MASI
  • PDSB
  • TDOC
Assets Removed
Asset Action Perf %
IRMD Sell All -2.14%
FOLD Sell All 7.79%
ESPR Sell All 27.07%
STAA Buy All -8.41%
Assets Rebalanced
None
2024-06-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 13.41% 7.69%
ESPR Esperion Therapeutics, Inc. Buy 15.72% 26.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.87% 11.21%
AGIO Agios Pharmaceuticals, Inc. Buy 10.89% 1.31%
MDGL Madrigal Pharmaceuticals, Inc. Buy 6.86% 12.14%
ACRS Aclaris Therapeutics, Inc. Buy 14.23% 2.68%
SGRY Surgery Partners, Inc. Buy 13.26% 0%
IRMD IRadimed Corporation Buy 13.26% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.26% 0%
EDIT Editas Medicine, Inc. Buy 13.26% 0%
STAA STAAR Surgical Company Sell -6.25% -6.18%
MCRB Seres Therapeutics, Inc. Sell -7.15% -21.43%
ABUS Arbutus Biopharma Corporation Sell -5.98% -1.56%
PEN Penumbra, Inc. Sell -5.48% -1.97%
ALT Altimmune, Inc. Sell -5.47% -1.92%
The percentage of cash held in the portfolio is: 2.34%
New Assets Added
  • SGRY
  • IRMD
  • ARWR
  • EDIT
Assets Removed
Asset Action Perf %
MDRX Sell All 0%
ANIK Sell All 1.79%
TVTX Sell All 7.31%
Assets Rebalanced
None
2024-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.74% 0%
ANIK Anika Therapeutics, Inc. Buy 12.85% 0.86%
TVTX Travere Therapeutics, Inc. Buy 13.17% 3.36%
FOLD Amicus Therapeutics, Inc. Buy 13.41% 5.26%
ESPR Esperion Therapeutics, Inc. Buy 16.13% 26.64%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.15% 3.14%
AGIO Agios Pharmaceuticals, Inc. Buy 11.03% 0.34%
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.17% 14.56%
ACRS Aclaris Therapeutics, Inc. Buy 14.17% 0%
STAA STAAR Surgical Company Sell -6.03% -0.16%
MCRB Seres Therapeutics, Inc. Sell -7.8% -29.43%
ABUS Arbutus Biopharma Corporation Sell -5.99% 0.62%
PEN Penumbra, Inc. Sell -5.55% -1%
ALT Altimmune, Inc. Sell -5.68% -3.51%
The percentage of cash held in the portfolio is: 17.22%
New Assets Added
  • ACRS
Assets Removed
Asset Action Perf %
DVA Sell All -4.66%
Assets Rebalanced
None
2024-06-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.77% 0.53%
DVA DaVita Inc. Buy 12.26% -3.48%
ANIK Anika Therapeutics, Inc. Buy 12.74% 0.27%
TVTX Travere Therapeutics, Inc. Buy 13.51% 6.29%
FOLD Amicus Therapeutics, Inc. Buy 12.92% 1.72%
ESPR Esperion Therapeutics, Inc. Buy 16.14% 27.07%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.3% 4.56%
AGIO Agios Pharmaceuticals, Inc. Buy 10.93% -0.27%
MDGL Madrigal Pharmaceuticals, Inc. Buy 6.24% 0%
STAA STAAR Surgical Company Sell -5.92% 1.53%
MCRB Seres Therapeutics, Inc. Sell -7.24% -20.52%
ABUS Arbutus Biopharma Corporation Sell -5.89% 1.87%
PEN Penumbra, Inc. Sell -5.48% 0%
ALT Altimmune, Inc. Sell -5.48% 0%
The percentage of cash held in the portfolio is: 19.19%
New Assets Added
  • MDGL
  • PEN
  • ALT
Assets Removed
None
Assets Rebalanced
None
2024-06-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.63% -0.53%
DVA DaVita Inc. Buy 12.39% -2.39%
ANIK Anika Therapeutics, Inc. Buy 12.77% 0.59%
TVTX Travere Therapeutics, Inc. Buy 13.23% 4.24%
FOLD Amicus Therapeutics, Inc. Buy 12.9% 1.72%
ESPR Esperion Therapeutics, Inc. Buy 15.51% 22.27%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.1% 3.14%
AGIO Agios Pharmaceuticals, Inc. Buy 11.01% 0.55%
STAA STAAR Surgical Company Sell -6% 0%
MCRB Seres Therapeutics, Inc. Sell -6% 0%
ABUS Arbutus Biopharma Corporation Sell -6% 0%
The percentage of cash held in the portfolio is: 14.46%
New Assets Added
  • STAA
  • MCRB
  • ABUS
Assets Removed
Asset Action Perf %
TNDM Sell All -5.57%
CUTR Buy All 6.8%
CARA Buy All 7%
CPRX Buy All 1.58%
VERU Buy All 25.2%
SENS Buy All 7.66%
Assets Rebalanced
None
2024-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.19% -4.18%
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.85% 0%
DVA DaVita Inc. Buy 12.6% -1.94%
ANIK Anika Therapeutics, Inc. Buy 13.15% 2.34%
TVTX Travere Therapeutics, Inc. Buy 13.58% 5.7%
FOLD Amicus Therapeutics, Inc. Buy 13.34% 3.95%
ESPR Esperion Therapeutics, Inc. Buy 13.85% 7.86%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.38% 4.06%
AGIO Agios Pharmaceuticals, Inc. Buy 11.18% 0.95%
CUTR Cutera, Inc. Sell -5.58% 4.85%
CARA Cara Therapeutics, Inc. Sell -5.62% 4.32%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.83% 0.69%
VERU Veru Inc. Sell -4.39% 25.2%
SENS Senseonics Holdings, Inc. Sell -5.57% 5.18%
The percentage of cash held in the portfolio is: 13.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All -7.14%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.56% -1.04%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.12% 1.37%
DVA DaVita Inc. Buy 12.65% -2.3%
ANIK Anika Therapeutics, Inc. Buy 13.32% 2.93%
TVTX Travere Therapeutics, Inc. Buy 14.52% 12.13%
FOLD Amicus Therapeutics, Inc. Buy 13.25% 2.43%
ESPR Esperion Therapeutics, Inc. Buy 12.71% -1.75%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.21% 1.94%
MD Pediatrix Medical Group, Inc. Buy 12.76% -1.21%
AGIO Agios Pharmaceuticals, Inc. Buy 11.16% 0%
CUTR Cutera, Inc. Sell -5.97% -0.97%
CARA Cara Therapeutics, Inc. Sell -5.85% 1.04%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.98% -1.07%
VERU Veru Inc. Sell -4.86% 17.89%
SENS Senseonics Holdings, Inc. Sell -5.6% 5.41%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AGIO
Assets Removed
Asset Action Perf %
VKTX Sell All -13.97%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.58% 0.48%
VKTX Viking Therapeutics, Inc. Buy 12.17% -4.73%
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.91% 1.05%
DVA DaVita Inc. Buy 12.68% -0.74%
ANIK Anika Therapeutics, Inc. Buy 13.3% 4.06%
TVTX Travere Therapeutics, Inc. Buy 14.42% 12.87%
FOLD Amicus Therapeutics, Inc. Buy 12.96% 1.52%
ESPR Esperion Therapeutics, Inc. Buy 12.49% -2.18%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.1% 2.47%
MD Pediatrix Medical Group, Inc. Buy 12.75% 0%
CUTR Cutera, Inc. Sell -6.32% -8.25%
CARA Cara Therapeutics, Inc. Sell -5.92% -1.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.95% -1.95%
VERU Veru Inc. Sell -4.79% 17.89%
SENS Senseonics Holdings, Inc. Sell -5.39% 7.66%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
Assets Removed
None
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.64% -0.97%
VKTX Viking Therapeutics, Inc. Buy 12.43% -4.74%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.04% 0%
DVA DaVita Inc. Buy 13.08% 0.29%
ANIK Anika Therapeutics, Inc. Buy 13.05% 0.04%
TVTX Travere Therapeutics, Inc. Buy 14.15% 8.48%
FOLD Amicus Therapeutics, Inc. Buy 12.93% -0.81%
ESPR Esperion Therapeutics, Inc. Buy 12.3% -5.68%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.05% 0%
CUTR Cutera, Inc. Sell -6.22% -4.37%
CARA Cara Therapeutics, Inc. Sell -5.76% 3.28%
CPRX Catalyst Pharmaceuticals, Inc. Sell -6.07% -1.89%
VERU Veru Inc. Sell -4.89% 17.89%
SENS Senseonics Holdings, Inc. Sell -5.77% 3.15%
The percentage of cash held in the portfolio is: 15.05%
New Assets Added
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-05-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.89% 3.29%
VKTX Viking Therapeutics, Inc. Buy 12.13% -5.48%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.19% 2.74%
DVA DaVita Inc. Buy 12.87% 0.31%
ANIK Anika Therapeutics, Inc. Buy 12.87% 0.27%
TVTX Travere Therapeutics, Inc. Buy 13.17% 2.63%
FOLD Amicus Therapeutics, Inc. Buy 12.83% 0%
ESPR Esperion Therapeutics, Inc. Buy 12.83% 0%
CUTR Cutera, Inc. Sell -5.92% -0.97%
CARA Cara Therapeutics, Inc. Sell -5.23% 10.88%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.95% -1.51%
VERU Veru Inc. Sell -4.62% 21.14%
SENS Senseonics Holdings, Inc. Sell -5.71% 2.7%
The percentage of cash held in the portfolio is: 27.65%
New Assets Added
  • FOLD
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.73% 0.04%
VKTX Viking Therapeutics, Inc. Buy 12.72% -2.37%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.03% 0%
DVA DaVita Inc. Buy 13.03% 0%
ANIK Anika Therapeutics, Inc. Buy 13.03% 0%
TVTX Travere Therapeutics, Inc. Buy 13.03% 0%
CUTR Cutera, Inc. Sell -6.5% -9.22%
CARA Cara Therapeutics, Inc. Sell -5.47% 8.05%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.96% -0.06%
VERU Veru Inc. Sell -4.84% 18.7%
SENS Senseonics Holdings, Inc. Sell -5.9% 0.9%
The percentage of cash held in the portfolio is: 54.11%
New Assets Added
  • MDRX
  • DVA
  • ANIK
  • TVTX
Assets Removed
None
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.94% 2.26%
VKTX Viking Therapeutics, Inc. Buy 13.03% 0%
CUTR Cutera, Inc. Sell -5.84% 1.94%
CARA Cara Therapeutics, Inc. Sell -5.96% -0.15%
CPRX Catalyst Pharmaceuticals, Inc. Sell -6.22% -4.41%
VERU Veru Inc. Sell -5.37% 9.76%
SENS Senseonics Holdings, Inc. Sell -5.83% 2.03%
The percentage of cash held in the portfolio is: 106.25%
New Assets Added
  • VKTX
Assets Removed
None
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.8% 0%
CUTR Cutera, Inc. Sell -6% 0%
CARA Cara Therapeutics, Inc. Sell -6% 0%
CPRX Catalyst Pharmaceuticals, Inc. Sell -6% 0%
VERU Veru Inc. Sell -6% 0%
SENS Senseonics Holdings, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 120.2%
New Assets Added
  • TNDM
  • CUTR
  • CARA
  • CPRX
  • VERU
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HCSG Buy All -1.82%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Sell 3.35% 0%
The percentage of cash held in the portfolio is: 96.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
ADUS Sell All 12.14%
Assets Rebalanced
None
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ADUS Addus HomeCare Corporation Buy 13.19% 9.52%
HCSG Healthcare Services Group, Inc. Sell 3.31% 1.64%
The percentage of cash held in the portfolio is: 83.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANIP Sell All 0.88%
BGNE Sell All 15.52%
CYH Sell All 13.85%
Assets Rebalanced
None
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANIP ANI Pharmaceuticals, Inc. Buy 12.38% 1.84%
BGNE BeiGene, Ltd. Buy 14.21% 16.9%
CYH Community Health Systems, Inc. Buy 13.88% 14.19%
ADUS Addus HomeCare Corporation Buy 12.41% 2.5%
HCSG Healthcare Services Group, Inc. Sell 3.33% 1.55%
The percentage of cash held in the portfolio is: 43.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All 8.04%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 13.14% 4.4%
ANIP ANI Pharmaceuticals, Inc. Buy 12.38% -0.21%
BGNE BeiGene, Ltd. Buy 13.75% 10.76%
CYH Community Health Systems, Inc. Buy 13.84% 11.49%
ADUS Addus HomeCare Corporation Buy 12.45% 0.68%
HCSG Healthcare Services Group, Inc. Sell 3.33% 3.45%
The percentage of cash held in the portfolio is: 31.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All -5.4%
TDOC Buy All 2.89%
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 13.42% 6.31%
ANIP ANI Pharmaceuticals, Inc. Buy 12.33% -0.97%
BGNE BeiGene, Ltd. Buy 14.02% 12.62%
BRKR Bruker Corporation Buy 12.27% -1.46%
CYH Community Health Systems, Inc. Buy 13.84% 11.15%
ADUS Addus HomeCare Corporation Buy 12.23% -1.38%
TDOC Teladoc Health, Inc. Sell -20.58% -1.98%
HCSG Healthcare Services Group, Inc. Sell 3.42% 1.27%
The percentage of cash held in the portfolio is: 39.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All -7.14%
AADI Buy All -10.71%
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 12.82% -7.14%
BLFS BioLife Solutions, Inc. Buy 13.14% 4.35%
ANIP ANI Pharmaceuticals, Inc. Buy 12.28% -1.18%
BGNE BeiGene, Ltd. Buy 13.73% 10.5%
BRKR Bruker Corporation Buy 12.2% -1.81%
CYH Community Health Systems, Inc. Buy 14.23% 14.53%
ADUS Addus HomeCare Corporation Buy 12.25% -1.01%
TDOC Teladoc Health, Inc. Sell -19.95% 0.91%
HCSG Healthcare Services Group, Inc. Sell 3.41% 1.36%
AADI Aadi Bioscience, Inc. Sell 3.6% -4.17%
The percentage of cash held in the portfolio is: 22.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORMP Buy All -11.82%
Assets Rebalanced
None
2024-04-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 12.55% -10.71%
BLFS BioLife Solutions, Inc. Buy 12.87% 0.36%
ANIP ANI Pharmaceuticals, Inc. Buy 12.42% -1.8%
BGNE BeiGene, Ltd. Buy 13.52% 6.89%
BRKR Bruker Corporation Buy 12.36% -2.27%
CYH Community Health Systems, Inc. Buy 13.89% 9.8%
ADUS Addus HomeCare Corporation Buy 12.1% -3.98%
TDOC Teladoc Health, Inc. Sell -20.81% -1.52%
ORMP Oramed Pharmaceuticals Inc. Sell -19.74% -4.55%
HCSG Healthcare Services Group, Inc. Sell 3.52% 0%
AADI Aadi Bioscience, Inc. Sell 3.52% 0%
The percentage of cash held in the portfolio is: 43.82%
New Assets Added
  • HCSG
  • AADI
Assets Removed
Asset Action Perf %
ATRI Buy All 1.02%
AVNS Buy All 6.89%
BLUE Buy All 21.55%
Assets Rebalanced
None
2024-04-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 12.4% -12.5%
BLFS BioLife Solutions, Inc. Buy 13.22% 2.32%
ANIP ANI Pharmaceuticals, Inc. Buy 12.61% -1.07%
BGNE BeiGene, Ltd. Buy 13.22% 3.69%
BRKR Bruker Corporation Buy 12.71% -0.32%
CYH Community Health Systems, Inc. Buy 13.05% 2.36%
ADUS Addus HomeCare Corporation Buy 12.7% 0%
ATRI Atrion Corporation Sell 12.7% -5.23%
AVNS Avanos Medical, Inc. Sell 3.44% 2.4%
BLUE bluebird bio, Inc. Sell 2.79% 20.69%
TDOC Teladoc Health, Inc. Sell -21.6% -4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -20.5% -7.73%
The percentage of cash held in the portfolio is: 33.27%
New Assets Added
  • ATRI
  • ADUS
Assets Removed
None
Assets Rebalanced
None
2024-04-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 13.13% -7.14%
BLFS BioLife Solutions, Inc. Buy 13.07% 1.31%
CYH Community Health Systems, Inc. Buy 12.72% 0%
BRKR Bruker Corporation Buy 12.72% 0%
BGNE BeiGene, Ltd. Buy 12.72% 0%
ANIP ANI Pharmaceuticals, Inc. Buy 12.72% 0%
ATRI Atrion Corporation Sell 3.53% -0.54%
AVNS Avanos Medical, Inc. Sell 3.44% 2.14%
BLUE bluebird bio, Inc. Sell 2.94% 16.38%
TDOC Teladoc Health, Inc. Sell -21.58% -4.65%
ORMP Oramed Pharmaceuticals Inc. Sell -20.29% -6.82%
The percentage of cash held in the portfolio is: 54.86%
New Assets Added
  • CYH
  • BRKR
  • BGNE
  • ANIP
Assets Removed
Asset Action Perf %
KIDS Sell All 0.76%
Assets Rebalanced
None
2024-04-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 12.15% -0.66%
SGMO Sangamo Therapeutics, Inc. Buy 12.86% -8.93%
BLFS BioLife Solutions, Inc. Buy 12.87% 0%
ATRI Atrion Corporation Sell 3.48% 0.81%
AVNS Avanos Medical, Inc. Sell 3.47% 1.15%
BLUE bluebird bio, Inc. Sell 2.87% 18.1%
TDOC Teladoc Health, Inc. Sell -20.85% -1.29%
ORMP Oramed Pharmaceuticals Inc. Sell -20.08% -5.91%
The percentage of cash held in the portfolio is: 93.23%
New Assets Added
  • BLFS
Assets Removed
Asset Action Perf %
ORGO Sell All 0%
PODD Sell All -3.31%
Assets Rebalanced
None
2024-04-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.99% -3.7%
PODD Insulet Corporation Buy 11.33% -3.12%
KIDS OrthoPediatrics Corp. Buy 11.86% -3.09%
SGMO Sangamo Therapeutics, Inc. Buy 12.36% -12.5%
ATRI Atrion Corporation Sell 3.36% 4.32%
AVNS Avanos Medical, Inc. Sell 3.42% 2.45%
BLUE bluebird bio, Inc. Sell 2.87% 18.1%
TDOC Teladoc Health, Inc. Sell -20.68% -0.38%
ORMP Oramed Pharmaceuticals Inc. Sell -18.98% 0%
The percentage of cash held in the portfolio is: 82.46%
New Assets Added
  • ORMP
Assets Removed
Asset Action Perf %
MDGL Sell All -10.86%
GKOS Sell All -5.47%
CDXS Buy All 12.77%
Assets Rebalanced
None
2024-04-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.55% -3.7%
GKOS Glaukos Corporation Buy 11.29% -3.66%
PODD Insulet Corporation Buy 11.45% 1.57%
KIDS OrthoPediatrics Corp. Buy 11.71% -0.72%
MDGL Madrigal Pharmaceuticals, Inc. Buy 11.02% -6.56%
SGMO Sangamo Therapeutics, Inc. Buy 13.13% -3.57%
CDXS Codexis, Inc. Sell -19.76% 14.95%
ATRI Atrion Corporation Sell 3.43% -1.5%
AVNS Avanos Medical, Inc. Sell 3.29% 2.71%
BLUE bluebird bio, Inc. Sell 2.89% 14.66%
TDOC Teladoc Health, Inc. Sell -19.85% 0%
The percentage of cash held in the portfolio is: 59.85%
New Assets Added
  • TDOC
Assets Removed
Asset Action Perf %
NKTR Sell All -10.78%
SMTI Buy All 10.11%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.04% -7.07%
GKOS Glaukos Corporation Buy 11.16% -3.77%
PODD Insulet Corporation Buy 11.41% 2.29%
KIDS OrthoPediatrics Corp. Buy 11.69% 0.16%
MDGL Madrigal Pharmaceuticals, Inc. Buy 10.83% -7.21%
NKTR Nektar Therapeutics Buy 16.78% -5.99%
SGMO Sangamo Therapeutics, Inc. Buy 13.48% 0%
SMTI Sanara MedTech Inc. Sell -19.13% 8.41%
CDXS Codexis, Inc. Sell -19.27% 16.2%
ATRI Atrion Corporation Sell 3.31% 1.1%
AVNS Avanos Medical, Inc. Sell 3.29% 1.67%
BLUE bluebird bio, Inc. Sell 2.97% 11.21%
The percentage of cash held in the portfolio is: 42.43%
New Assets Added
  • SGMO
Assets Removed
Asset Action Perf %
SAVA Sell All -15.1%
TDOC Sell All -10.03%
BCRX Sell All -8.43%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.23% -3.03%
GKOS Glaukos Corporation Buy 11.04% -2.38%
PODD Insulet Corporation Buy 11.21% 3.05%
SAVA Cassava Sciences, Inc. Buy 10.2% -3.48%
TDOC Teladoc Health, Inc. Buy 10.75% -5.64%
KIDS OrthoPediatrics Corp. Buy 11.65% 2.27%
MDGL Madrigal Pharmaceuticals, Inc. Buy 10.81% -5.11%
BCRX BioCryst Pharmaceuticals, Inc. Buy 16.25% -6.47%
NKTR Nektar Therapeutics Buy 17.41% 0%
SMTI Sanara MedTech Inc. Sell -19.4% 4.8%
CDXS Codexis, Inc. Sell -20.05% 10.59%
ATRI Atrion Corporation Sell 3.24% 0.93%
AVNS Avanos Medical, Inc. Sell 3.15% 3.44%
BLUE bluebird bio, Inc. Sell 3.1% 5.17%
The percentage of cash held in the portfolio is: 19.41%
New Assets Added
  • NKTR
Assets Removed
None
Assets Rebalanced
None
2024-04-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.32% 1.01%
GKOS Glaukos Corporation Buy 10.8% -1.36%
PODD Insulet Corporation Buy 11.12% 5.65%
SAVA Cassava Sciences, Inc. Buy 11.33% 10.78%
TDOC Teladoc Health, Inc. Buy 10.69% -3.05%
KIDS OrthoPediatrics Corp. Buy 11.44% 3.82%
MDGL Madrigal Pharmaceuticals, Inc. Buy 10.84% -1.63%
BCRX BioCryst Pharmaceuticals, Inc. Buy 16.82% 0%
SMTI Sanara MedTech Inc. Sell -18.45% 6.42%
CDXS Codexis, Inc. Sell -21.03% 3.12%
ATRI Atrion Corporation Sell 3.16% 0%
AVNS Avanos Medical, Inc. Sell 3.16% 0%
BLUE bluebird bio, Inc. Sell 3.16% 0%
The percentage of cash held in the portfolio is: 35.63%
New Assets Added
  • BCRX
  • ATRI
  • AVNS
  • BLUE
Assets Removed
Asset Action Perf %
VERU Sell All 115.66%
ALPN Sell All 65.38%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings